NCT06541678View on ClinicalTrials.gov

A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 23, 2024

Primary Completion Date

March 10, 2025

Study Completion Date

March 10, 2025

Conditions
Healthy
Interventions
DRUG

Danuglipron

MR Tablet

DRUG

Cyclosporine

Capsule

DRUG

Itraconazole

Oral solution

Trial Locations (1)

06511

Pfizer Clinical Research Unit - New Haven, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06541678 - A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults. | Biotech Hunter | Biotech Hunter